To include your compound in the COVID-19 Resource Center, submit it here.

Unigene, China Shijiazhuang Pharmaceutical Group Co. Ltd. deal

Unigene said it will sell its 45% stake in Unigene Biotechnology Co. Ltd., a JV with Shijiazhuang's China Pharmaceutical Group

Read the full 208 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE